197 related articles for article (PubMed ID: 263348)
1. Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
Santen RJ; Santner S; Davis B; Veldhuis J; Samojlik E; Ruby E
J Clin Endocrinol Metab; 1978 Dec; 47(6):1257-65. PubMed ID: 263348
[No Abstract] [Full Text] [Related]
2. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
Samojlik E; Santen RJ; Kirschner MA; Ertel NH
Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
[TBL] [Abstract][Full Text] [Related]
3. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Santen RJ
Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
[TBL] [Abstract][Full Text] [Related]
4. Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.
Samojlik E; Santen RJ; Wells SA
J Clin Endocrinol Metab; 1977 Sep; 45(3):480-7. PubMed ID: 903399
[No Abstract] [Full Text] [Related]
5. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
[TBL] [Abstract][Full Text] [Related]
7. Estrogen synthesis and estradiol binding by human mammary tumors.
Varela RM; Dao TL
Cancer Res; 1978 Aug; 38(8):2429-33. PubMed ID: 667840
[No Abstract] [Full Text] [Related]
8. Mechanism of action of aminoglutethimide in breast cancer.
Santen RJ; Veldhuis J; Samojlik E; Lipton A; Harvey H; Wells SA
Lancet; 1979 Jan; 1(8106):44-5. PubMed ID: 83490
[No Abstract] [Full Text] [Related]
9. Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
Harris AL; Dowsett M; Cantwell BM; Sainsbury JR; Needham G; Farndon J; Wilson R
Breast Cancer Res Treat; 1986; 7 Suppl():S69-72. PubMed ID: 2943338
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
Lønning PE; Dowsett M; Powles TJ
J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151
[TBL] [Abstract][Full Text] [Related]
11. Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer.
Harris AL; Dowsett M; Jeffcoate SL; McKinna JA; Morgan M; Smith IE
J Clin Endocrinol Metab; 1982 Oct; 55(4):718-22. PubMed ID: 6213633
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer.
Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A
Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526
[TBL] [Abstract][Full Text] [Related]
13. Effects of aminoglutethimide on delta 5-androstenediol metabolism in postmenopausal women with breast cancer.
Bird CE; Masters V; Sterns EE; Clark AF
Cancer Res; 1982 Nov; 42(11):4797-800. PubMed ID: 6290048
[TBL] [Abstract][Full Text] [Related]
14. Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.
Reed MJ; Beranek PA; Ghilchik MW; James VH
Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1395-400. PubMed ID: 3830220
[TBL] [Abstract][Full Text] [Related]
15. Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
Dowsett M; Santner SJ; Santen RJ; Jeffcoate SL; Smith IE
Br J Cancer; 1985 Jul; 52(1):31-5. PubMed ID: 4015950
[TBL] [Abstract][Full Text] [Related]
16. The origin of androgen and estrogen in a virilized postmenopausal woman with bilateral benign cystic teratomas.
Aiman J; Nalick RH; Jacobs A; Porter JC; Edman CD; Vellios F; MacDonald PC
Obstet Gynecol; 1977 Jun; 49(6):695-704. PubMed ID: 865733
[TBL] [Abstract][Full Text] [Related]
17. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
[TBL] [Abstract][Full Text] [Related]
18. Plasma estrone-sulfate: assessment of reduced estrogen production during treatment of metastatic breast carcinoma.
Samojlik E; Santen RJ; Worgul TJ
Steroids; 1982 May; 39(5):497-507. PubMed ID: 6293125
[TBL] [Abstract][Full Text] [Related]
19. Extraglandular estrogen production in postmenopausal women with and without endometrial cancer: comparison between "in vitro" and "in vivo" results.
Jasonni VM; Lodi S; Preti S; Bonavia M; Bulletti C; Bolelli G; Franceschetti F; Flamigni C
Cancer Detect Prev; 1981; 4(1-4):469-73. PubMed ID: 7349812
[No Abstract] [Full Text] [Related]
20. Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients.
Poortman J; Thijssen JH; Schwarz F
J Clin Endocrinol Metab; 1973 Jul; 37(1):101-9. PubMed ID: 4268455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
